[1]
S. Ciotti et al., “Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health”, EJCRIM, vol. 8, no. 9, Oct. 2021, doi: 10.12890/2021_002298.